Evidence map›Paper›PMID 40992685›Full record

ArticleThe Journal of investigative dermatology2026

Melanin-Driven Delayed CPD Formation Is Independent of Melanin Biosynthesis Pathway.

Vipin K Yadav, Jyoti Srivastava, Avanthika Venkatachalam, Mukund P Tantak, Nicholas J Lawrence, David E Fisher, Harshani R Lawrence, Sanjay Premi

Abstract read
In one paragraph

Article in The Journal of investigative dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vipin K YadavDepartment of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Jyoti SrivastavaDepartment of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Electronic address: Jyoti.srivastava@moffitt.org.
Avanthika VenkatachalamCutaneous Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Mukund P TantakChemical Biology Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Nicholas J LawrenceDepartment of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
David E FisherCutaneous Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Harshani R LawrenceChemical Biology Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA; Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Sanjay PremiDepartment of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Electronic address: Sanjay.premi@moffitt.org.

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
Transcriptional mechanisms and melanomaP01CA163222 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI DAVID E FISHER · 2013 to 2026
$25.3M
The MITF transcriptional network: melanoma risk and carcinogenesisR01AR043369 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI DAVID E FISHER · 1996 to 2026
$9.4M
Therapeutic strategies for treatment of giant congenital melanocytic neviR01AR072304 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI DAVID E FISHER · 2017 to 2026
$3.9M
Developing Chemical Probes for Oncogenic Signaling PathwaysR50CA211447 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI Harshani R Lawrence · 2017 to 2026
$2.2M
Novel role of melanin-carbonyls in progression of NRAS mutant melanomaR21ES035196 · NIEHS · H. LEE MOFFITT CANCER CTR & RES INST · PI PREMI, SANJAY · 2023 to 2023
$463k
NCI NIH HHS P01 CA163222NCI NIH HHS P30 CA076292NCI NIH HHS R50 CA211447NIAMS NIH HHS R01 AR043369NIAMS NIH HHS R01 AR072304NIEHS NIH HHS R21 ES035196
6 · The paper itself

Abstract

Cyclobutane pyrimidine dimers (CPDs) are the major form of DNA damage induced by UVR. Although CPDs form instantaneously during UV exposure, our prior studies demonstrated that melanin chemiexcitation, in which UV-induced peroxynitrite oxidizes melanin into excited-state intermediates, continues to generate CPDs for hours after UV exposure ends. These "delayed" CPDs contribute up to 50% of the total CPD burden. Although melanin's involvement is well-established, it remains unclear whether active melanin biosynthesis is required or whether the mere presence of pigment is sufficient. To address this, we developed a depigmentation-repigmentation system using cultured melanocytes. Cells were depigmented in tyrosine-deficient medium and repigmented either by reintroducing tyrosine or by supplementing with 5,6-dihydroxyindole-2-carboxylic acid, a melanin monomer that polymerizes nonenzymatically. In both conditions, delayed CPD formation was restored. Notably, 5,6-dihydroxyindole-2-carboxylic acid treatment alone was sufficient to induce pigmentation and delayed CPD formation even in tyrosinase-deficient isogenic albino melanocytes. Pigment accumulation was also associated with nitric oxide synthase activity, a key contributor to chemiexcitation, although the mechanisms linking melanin synthesis to nitric oxide synthase activity remain to be elucidated. These findings demonstrated pigment presence, not biosynthesis, as the key determinant of delayed CPD formation, with broad implications for photobiology, pigmentation, and skin cancer risk.

Indexed as

MelaninsMelanocytesPyrimidine DimersAnimalsCells, CulturedDNA DamageHumansIndolesMiceSkin PigmentationTyrosineUltraviolet Rays5,6-dihydroxy-2-indolylcarboxylic acidIndolesMelaninsPyrimidine DimersTyrosineDelayed CPDs (dCPDs)Incidental CPDs (iCPDs)Melanin monomersMelanin synthesisUVA radiation

Identifiers

PMID40992685
PMCPMC12507450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.